- Amended Annual Report (10-K/A)
July 15 2009 - 4:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
(Mark One)
x
|
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended February 28, 2009
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from
to
Commission file number 000-23425
BURZYNSKI RESEARCH INSTITUTE, INC.
(Exact name of registrant as
specified in its charter)
Delaware
|
|
76-0136810
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
9432 Old Katy Road, Suite 200
|
|
|
Houston, Texas
|
|
77055
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone
number, including area code:
(713) 335-5697
Securities registered under Section 12(b) of
the Exchange Act:
None
Securities registered under Section 12(g) of
the Exchange Act:
Common Stock, $.001 par value
Indicate by check mark if
the registrant is a well-known seasoned issuer, as defined in Rule 405 of
the Securities Act. Yes
o
No
x
Indicate by check mark if
the registrant is not required to file reports pursuant to Section 13 or
15(d) of the Act. Yes
x
No
o
Indicate by check mark
whether the registrant (1) has filed all reports required to be filed by Section 13
or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file
such reports) and (2) has been subject to such filing requirements for the
past 90 days. Yes
x
No
o
Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate
Web site, if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).
Yes
o
No
o
Indicate by check mark if
disclosure of delinquent filers pursuant to Item 405 of Regulation S-K
(§ 229.405) is not contained herein, and will not contain, to the best of
registrants knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any
amendment of this Form 10-K.
x
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, or a
non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer,
accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large
accelerated filer
o
|
|
Accelerated
filer
o
|
|
|
|
Non-accelerated
filer
o
(Do not check if
a smaller reporting company)
|
|
Smaller
reporting company
x
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2
of the Act). Yes
o
No
x
As of May 1, 2009,
the aggregate market value of the Common Stock held by non-affiliates was
approximately $3,168,653.02 based on the last reported sales price on May 1,
2009.
As of May 1, 2009,
there were 131,388,444 shares of the Registrants Common Stock outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
Documents
incorporated by reference: None.
Explanatory Note
Burzynski Research Institute, Inc. (the Company)
is filing this Amendment No. 1 amending its Annual Report on Form 10-K
for the year ended February 28, 2009, which was filed with the Securities
and Exchange Commission on May 29, 2009 (the Original Filing). The Company is filing this Amendment No. 1
for the sole purpose of replacing Exhibit 23.1 with the corrected consent
of Fitts, Roberts & Co., P.C.
Amendment No. 1 does not include the entire Form 10-K.
Except as described above, no other changes have
been made to the Original Filing. The
Original Filing continues to speak as of the date of the Original Filing, and
the Company has not updated the disclosures contained therein to reflect any
events which occurred subsequent to the filing of the Original Filing, or to modify
the disclosure contained in the Original Filing other than to reflect the
changes described above.
ITEM 15.
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES
EXHIBIT NO.
|
|
EXHIBIT NAME
|
|
|
|
3.1
|
|
Certificate of Incorporation of the Company, as amended (incorporated
by reference from Exhibit 3(i) (iii) to Form 10-SB
filed with the Securities and Exchange Commission on November 25, 1997
(File No. 000-23425)).
|
|
|
|
3.2
|
|
Amended Bylaws of the Company (incorporated by reference from
Exhibit (3)(iv) to Form 10-SB filed with the Securities and
Exchange Commission on November 25, 1997 (File No. 000-23425)).
|
|
|
|
4.1
|
|
Form of Certificate Representing Common Stock (incorporated by
reference from Exhibit 4.1 to Form 10-KSB filed with the Securities
and Exchange Commission on May 2, 2001 (File No. 000-23425)).
|
|
|
|
10.1
|
|
License Agreement, effective as of June 29, 1983, by and between
the Company and Dr. Stanislaw R. Burzynski (incorporated by reference
from Exhibit 10(1) to Form 10-SB filed with the Securities and
Exchange Commission on November 25, 1997 ( File No. 000-23425)).
|
|
|
|
10.2
|
|
Amended License Agreement, dated April 2, 1984, by and between the
Company and Dr. Stanislaw R. Burzynski (incorporated by referenced from
Exhibit 10(2) to Form 10-SB filed with the Securities and
Exchange Commission on November 25, 1997 (File No. 000-23425)).
|
|
|
|
10.3
|
|
Second Amended License Agreement, dated March 1, 1990, by and
between the Company and Dr. Stanislaw R. Burzynski (incorporated by
reference from Exhibit 10(3) to Form 10-SB filed with the
Securities and Exchange Commission on November 25, 1997 (File
No. 000-23425)).
|
|
|
|
10.4
|
|
Research Funding Agreement, effective as of March 1, 1997, by and
between the Company and Dr. Stanislaw R. Burzynski (incorporated by
reference from Exhibit 10(4) to Form 10-SB filed with the
Securities and Exchange Commission on November 25, 1997 (File
No. 000-23425)).
|
|
|
|
10.5
|
|
First Amendment to Research Funding Agreement, effective as of
March 1, 2001, by and between the Company and Dr. Stanislaw R.
Burzynski (incorporated by reference from Exhibit 10.5 to
Form 10-KSB filed with the Securities and Exchange Commission on
May 2, 2001 (File No. 000-23425)).
|
|
|
|
10.6
|
|
Second Amendment to the Research Funding Agreement, effective as of
February 29, 2004, by and between the Company and Dr. Stanislaw R.
Burzynski (incorporated by reference from Exhibit 10.6 to
Form 10-KSB filed with the Securities and Exchange Commission on
June 1, 2004 (File No. 000-23425)).
|
|
|
|
10.7
|
|
Royalty Agreement, dated March 25, 1997, by and between the
Company and Dr. Stanislaw R. Burzynski (incorporated by reference from
Exhibit 10(5) to Form 10-SB filed with the Securities and
Exchange Commission on November 25, 1997 (File No. 000-23425)).
|
|
|
|
10.8
|
|
First Amended Royalty Agreement, dated September 29, 1997, by and
between the Company and Dr. Stanislaw R. Burzynski (incorporated by
reference from Exhibit 10(6) to Form 10-SB filed with the
Securities and Exchange Commission on November 25, 1997 (File
No. 000-23425)).
|
|
|
|
10.9
|
|
Third Amendment to Research Funding Agreement, effective as of
March 1, 2007, by and between the Company and Dr. Stanislaw R.
Burzynski (incorporated by reference from Exhibit 10.9 to
Form 10-KSB filed with the Securities and Exchange Commission on
May 29, 2007 (File No. 000-23425)).
|
|
|
|
23.1
|
|
Consent of Fitts, Roberts & Co., P.C.
|
24
|
|
Power of Attorney (Included with the Signature Page).
|
|
|
|
31.1
|
|
Certification pursuant to Rules 13a-14 and 15d-14 of the
Securities Exchange Act of 1934, as amended, filed herewith (Chief Executive
Officer and Principal Financial Officer).
|
|
|
|
32.1
|
|
Certification furnished pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief
Executive Officer and Principal Financial Officer).
|
2
SIGNATURES
In accordance with Section 13 or 15(d) of
the Securities Exchange Act of 1934, the registrant caused this Amendment No. 1
to the Annual Report on Form 10-K/A to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
BURZYNSKI RESEARCH INSTITUTE, INC.
|
|
|
|
|
|
By:
|
/s/ Stanislaw R. Burzynski
|
|
|
Stanislaw R. Burzynski, President,
|
|
|
Secretary, Treasurer and Chairman of the
|
|
|
Board of Directors
|
|
|
|
|
Date: July 15, 2009
|
|
3
Each person whose signature appears below
constitutes and appoints Dr. Stanislaw R. Burzynski his/her true and
lawful attorney-in-fact and agent, with full power of substitution and resubstitution,
severally, for him/her in his/her name, place and stead, in any and all
capacities, to sign any and all amendments to this report, and to file the
same, with all exhibits thereto and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he/she might or could do in
person, hereby ratifying and confirming all that said attorney-in-fact and
agent may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities
Act of 1934, this report has been signed below by the following persons in the
capacities and on the dates indicated.
/s/ Stanislaw R. Burzynski
|
|
|
Stanislaw R. Burzynski
|
|
Date: July 15, 2009
|
President, Secretary, Treasurer and
|
|
|
Chairman of the Board of Directors
|
|
|
|
|
|
|
|
|
/s/ Barbara Burzynski
|
|
|
Barbara Burzynski
|
|
Date: July 15, 2009
|
Director
|
|
|
|
|
|
|
|
|
/s/ Michael H. Driscoll
|
|
|
Michael H. Driscoll
|
|
Date: July 15, 2009
|
Director
|
|
|
|
|
|
|
|
|
/s/ Carlton Hazlewood
|
|
|
Carlton Hazlewood
|
|
Date: July 15, 2009
|
Director
|
|
|
4
Burzynski Research Insti... (PK) (USOTC:BZYR)
Historical Stock Chart
From Jan 2025 to Feb 2025
Burzynski Research Insti... (PK) (USOTC:BZYR)
Historical Stock Chart
From Feb 2024 to Feb 2025